Join to View Full Profile
1401 Harrodsburg RdSuite B280Lexington, KY 40504
Phone+1 859-313-4989
Fax+1 859-313-3390
Dr. Fakhoury is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Vanderbilt University Medical CenterResidency, Neurology, 1990 - 1991
Good Samaritan Hospital of MarylandResidency, Internal Medicine, 1989 - 1990
University of Cincinnati Medical Center/College of MedicineResidency, Neurology, 1986 - 1989
American University of Beirut Faculty of MedicineClass of 1985
Certifications & Licensure
KY State Medical License 1999 - 2026
TN State Medical License 1991 - 2000
OH State Medical License 1988 - 1992
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension Start of enrollment: 2013 Oct 01
- A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures Start of enrollment: 2020 Jan 27
Roles: Contact
Publications & Presentations
PubMed
- 10 citationsPsychosocial outcomes of repeated treatment of seizure clusters with midazolam nasal spray: Results of a phase 3, open-label extension trial.Tze-Chiang Meng, Jerzy P Szaflarski, Linda Chen, Marcus Brunnert, Rita Campos
Epilepsy & Behavior. 2023-01-01 - 6 citationsLong-term safety and efficacy of brivaracetam in adults with focal seizures: Results from an open-label, multinational, follow-up trial.Stephan Arnold, Cédric Laloyaux, Anne-Liv Schulz, Sami Elmoufti, Stephen Yates
Epilepsy Research. 2020-06-23 - 14 citationsBrivaracetam-induced elevation of carbamazepine epoxide levels: A post-hoc analysis from the clinical development program.Martin J. Brodie, Toufic Fakhoury, Belinda McDonough, Anny-Odile Colson, Armel Stockis
Epilepsy Research. 2018-06-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
